Prostate cancer: diagnosis and management - National Institute for Health and Care Excellence (NICE)
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.
A table of NHS England interim treatment regimens gives possible alternative treatment options for use during the COVID-19 pandemic to reduce infection risk. This may affect decisions for patients with prostate cancer. See the COVID-19 rapid guideline: delivery of systemic anticancer treatments for more details.
In December 2021, we reviewed the evidence and updated the recommendations on risk stratification to refer to a 5-tier model. Other recommendations were amended to reflect this change. For more information, see the update information.
Read full guideline